Back to Evidence Hub
Case Study S004
2022 Release

Işilay Zeybek 2022: SCG in Cardiac Patients

Işilay Zeybek, Marco Di Rienzo et al.
Access Paper

Quick Conclusion: Identifies challenges in applying standard SCG analysis to patients with heart disease, noting signal distortion in 38% of the cohort.


📊 Key Accuracy Metrics

MetricResult
Traditional (T) shape prevalence62% of all patients (79% in MI, lower in HF/TX)
AO Mean Difference-1.3 ms (SD 18.3 ms)
MC Mean Difference-17.1 ms (SD 26.2 ms)
Accuracy range76-81% for AO, AC, MO within healthy reference range


🔍 Study Analysis

Objective & Population

Pilot Study / Validation in Clinical Population. Cohort: 90 patients (Myocardial Infarction, Heart Failure, Heart Transplant) (N=90).

What it Supports

Observes that 62% of cardiac patients retain traditional SCG morphology suitable for standard peak detection.

What it Does Not Support

The study does not support the universal application of standard SCG peak detection in all cardiac patients without preliminary verification. Specifically, patients with heart failure or heart transplants may have distorted waveforms that make automated peak detection inaccurate or impossible.


🛠 Technical Context

Featured Illustration

No caption found automatically.

Study Snapshot

Metadata Summary

Target Population

90 patients (Myocardial Infarction, Heart Failure, Heart Transplant)

N

Sample Size

90 Subjects

Validated Metric

62% of all patients (79% in MI, lower in HF/TX)

Critical Appraisal
supporting

Identified limitations of standard FP-based SCG analysis in patients with structural heart disease.